MedTrace Logo

Surface Monitoring Technology to Remove The Mask - Stage 1

NCT04266223 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-09

No results posted yet for this study

Summary

A pilot-stage device feasibility study investigating a mask-free motion-monitoring patient immobilisation system for use during radiation therapy treatment of head and neck cancer (HNC). This mask-free system combines the standard radiation therapy (RT) head rest to help the patient remain still with a surface guidance detection system that uses sensors to detect and track patient movement.

Patients who will have RT treatment for head and neck cancer involving an immobilisation mask will be asked to lie on the treatment couch for the normal treatment fraction time while the surface monitoring system is activated. We will then assess:

i) The level of acceptance of the system by HNC patients currently being treated with RT using an immobilisation mask, and ii) The ability of the surface guidance system to monitor movement of the patients

Conditions

Interventions

DEVICE

Mask-free surface monitoring

Mask-free headrest and couch for patient positioning for radiation therapy combined with a surface monitoring system

Sponsors & Collaborators

  • Western Sydney Local Health District

    collaborator OTHER

  • University of Sydney

    lead OTHER

Principal Investigators

  • Purmina Sundaresan, Dr · Western Sydney Local Health District

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-28
Primary Completion
2024-11-30
Completion
2024-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04266223 on ClinicalTrials.gov